Who Owns ZVRA?

Zevra Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$9.82

-0.26 (-2.53%)

Market Cap

$595.9M

Shares Outstanding

59,114,800

Institutional Holders

110

Total Inst. Value

$267.6M

% of Float Held

64.0%

QoQ Holder Change

+35

Institutional data as of Q1 2025

New Positions

23

Closed Positions

17

Increased

41

Decreased

27

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Woodline Partners LP$34.6M4,615,625
2BlackRock, Inc.$30.9M4,126,563
3ADAGE CAPITAL PARTNERS GP, L.L.C.$27.1M3,618,000
4VANGUARD GROUP INC$21.2M2,825,845
5FMR LLC$17.3M2,306,317
6Nantahala Capital Management, LLC$11.0M1,471,936
7AIGH Capital Management LLC$10.8M1,438,109
8Altium Capital Management LLC$9.6M1,287,333
9GEODE CAPITAL MANAGEMENT, LLC$9.2M1,233,111
10683 Capital Management, LLC$9.2M1,225,834

Biggest Buyers & Sellers This Quarter

Top Buyers

Related Stocks

Frequently Asked Questions

How many institutional investors hold ZVRA?

As of Q1 2025, 110 institutional investors report holding ZVRA (Zevra Therapeutics, Inc.) in their 13F filings.

What percentage of Zevra Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 64.0% of Zevra Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most ZVRA?

The largest institutional holder of ZVRA is Woodline Partners LP with $34.6M in shares.

Are institutions buying or selling ZVRA?

This quarter, 23 institutions opened new positions in ZVRA and 17 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.